Delcath Systems (DCTH) to Release Quarterly Earnings on Wednesday

Key Points

• Delcath Systems (DCTH) is set to announce its Q2 2025 earnings on Wednesday, August 6th, with expectations of earnings of $0.02 per share and revenue of $22.84 million.
• In its previous earnings report, Delcath Systems reported $0.03 EPS, missing estimates, and had a negative return on equity of 29.44% and net margin of 26.38%.
• Analysts have varying ratings for the stock, with HC Wainwright maintaining a "buy" rating and a price target of $29, while the average rating stands at "Moderate Buy" with a target of $24.00.

Delcath Systems (NASDAQ:DCTH - Get Free Report) is expected to be announcing its Q2 2025 earnings results before the market opens on Wednesday, August 6th. Analysts expect the company to announce earnings of $0.02 per share and revenue of $22.84 million for the quarter.

Delcath Systems (NASDAQ:DCTH - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.10 by ($0.07). The company had revenue of $19.80 million for the quarter, compared to analysts' expectations of $16.83 million. Delcath Systems had a negative net margin of 26.38% and a negative return on equity of 29.44%. On average, analysts expect Delcath Systems to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Delcath Systems Trading Down 1.5%

Shares of NASDAQ DCTH traded down $0.16 during trading on Friday, reaching $10.59. 533,260 shares of the company traded hands, compared to its average volume of 690,547. The firm's fifty day simple moving average is $13.54 and its 200 day simple moving average is $13.73. The stock has a market cap of $368.85 million, a P/E ratio of -21.18 and a beta of 0.82. Delcath Systems has a 12-month low of $7.17 and a 12-month high of $18.23.

Institutional Investors Weigh In On Delcath Systems

A hedge fund recently raised its stake in Delcath Systems stock. Millennium Management LLC boosted its position in shares of Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) by 34.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 422,066 shares of the company's stock after buying an additional 107,391 shares during the period. Millennium Management LLC owned 1.21% of Delcath Systems worth $5,373,000 at the end of the most recent quarter. Institutional investors own 61.12% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on DCTH shares. Wall Street Zen upgraded Delcath Systems from a "hold" rating to a "buy" rating in a research note on Saturday. Stephens restated an "overweight" rating and issued a $25.00 price target on shares of Delcath Systems in a research note on Monday, June 23rd. Finally, HC Wainwright restated a "buy" rating and issued a $29.00 price target (up previously from $24.00) on shares of Delcath Systems in a research note on Friday, May 23rd. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $24.00.

About Delcath Systems

Delcath Systems, Inc, an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.